Viewing Study NCT06631456



Ignite Creation Date: 2024-10-25 @ 8:02 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06631456
Status: COMPLETED
Last Update Posted: None
First Post: 2024-10-05

Brief Title: Effects of Platelet-Rich Plasma and Ozone Therapy in Knee Osteoarthritis
Sponsor: None
Organization: None

Study Overview

Official Title: Effects of Platelet-Rich Plasma and Ozone Therapy on Pain and Quality of Life in Knee Osteoarthritis A Retrospective Study
Status: COMPLETED
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Knee osteoarthritis can frequently occur with advancing age In cases of pain that persists despite hotcold applications drug therapy and exercise intra-articular injections are considered In advanced-stage gonarthrosis steroid injections may respond However in mild and moderate knee arthritis regenerative methods come to the forefront because the joint cartilage is still partiallycompletely intact PRP and ozone therapy are frequently applied intra-articular treatments This study will compare the effects of both injection methods on clinical outcomes
Detailed Description: Knee osteoarthritis is a common arthrosis that can be encountered frequently with increasing life expectancy In mild-moderate stages hotcold applications drug treatments and exercise applications are usually applied while in those who do not respond physical therapy or intra-articular injection treatments are applied This retrospective study aims to examine the effects of intra-articular Platelet Rich Plasma PRP and ozone therapy on pain functionality and quality of life in patients with Stage 2-3 gonarthrosis according to the Kelgren-Lawrence KL Classification

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None